Fluge, Ø., Bruland, O., Risa, K., Storstein, A., Kristoffersen, E. K., Sapkota, D., . . . Mella, O. (2011). Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study. Public Library of Science (PLoS).
Chicago Style (17th ed.) CitationFluge, Øystein, et al. Benefit from B-lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome. A Double-blind and Placebo-controlled Study. Public Library of Science (PLoS), 2011.
MLA (9th ed.) CitationFluge, Øystein, et al. Benefit from B-lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome. A Double-blind and Placebo-controlled Study. Public Library of Science (PLoS), 2011.
Warning: These citations may not always be 100% accurate.